23andMe Holding Future Growth
Future criteria checks 1/6
23andMe Holding is forecast to grow revenue at 11.6% per annum. EPS is expected to grow by 47.7% per annum.
Key information
n/a
Earnings growth rate
47.7%
EPS growth rate
| Healthcare earnings growth | 17.2% |
| Revenue growth rate | 11.6% |
| Future return on equity | -40.6% |
| Analyst coverage | Low |
| Last updated | 08 Feb 2024 |
Recent future growth updates
Recent updates
Here's Why We're A Bit Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation
Apr 16
Risks Still Elevated At These Prices As 23andMe Holding Co. (NASDAQ:ME) Shares Dive 26%
Mar 02We're Keeping An Eye On 23andMe Holding's (NASDAQ:ME) Cash Burn Rate
Jul 1323andMe Holding Co. (NASDAQ:ME) Investors Are Less Pessimistic Than Expected
Jun 1523andMe: Disappointing Results Could Mean Potential Acquisition Target
Sep 2723andMe: Treacherous Path To Profitability
Aug 2623andMe drops 8% as CFO resigns
Aug 1923andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target
Aug 1123andMe Q1 2023 Earnings Preview
Aug 0723andMe: Holiday Miracles Not Enough, Growth Path Too Expensive
Jun 1523andMe: A Genetics Innovator Positioned For Growth
Feb 19Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues
Feb 1823andMe: No Surprises With Recent Earnings, But Long-Term Story Remains Positive
Nov 2123andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains
Oct 03Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth
Sep 1723andMe: New Therapeutic Pipeline And PGS Product Growth Catalyzed By +$696M In SPAC Funding
Jul 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 304 | N/A | N/A | N/A | 1 |
| 3/31/2025 | 265 | N/A | N/A | N/A | 2 |
| 3/31/2024 | 217 | N/A | N/A | N/A | 2 |
| 12/31/2023 | 248 | -522 | -194 | -183 | N/A |
| 9/30/2023 | 270 | -336 | -158 | -146 | N/A |
| 6/30/2023 | 296 | -327 | -173 | -162 | N/A |
| 3/31/2023 | 299 | -312 | -177 | -165 | N/A |
| 12/31/2022 | 308 | -317 | -167 | -156 | N/A |
| 9/30/2022 | 298 | -315 | -216 | -206 | N/A |
| 6/30/2022 | 277 | -265 | -211 | -195 | N/A |
| 3/31/2022 | 272 | -217 | -181 | -167 | N/A |
| 12/31/2021 | 260 | -215 | -183 | -172 | N/A |
| 9/30/2021 | 259 | -170 | -130 | -119 | N/A |
| 6/30/2021 | 255 | -190 | -90 | -86 | N/A |
| 3/31/2021 | 244 | -184 | -82 | -74 | N/A |
| 3/31/2020 | 305 | -251 | -259 | -186 | N/A |
| 3/31/2019 | 441 | -184 | -126 | -98 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ME's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if ME's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if ME's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ME's revenue (11.6% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: ME's revenue (11.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ME is forecast to be unprofitable in 3 years.